Dow Up 0.59% Nasdaq Up 0.75%

Avanir Pharmaceuticals, Inc. (AVNR)

-NasdaqGS
12.06 0.43(3.44%)
Prev Close:12.49
Open:N/A
Bid:12.00 x 1000
Ask:12.20 x 2000
1y Target Est:8.73
Beta:1.05
Earnings Date:Dec 8 - Dec 12 (Est.)
Day's Range:11.23 - 12.20
52wk Range:2.62 - 13.09
Volume:N/A
Avg Vol (3m):3,831,560
Market Cap:N/A
P/E (ttm):N/A
EPS (ttm):-0.47
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in USD.

Comparison

Symbol% ChgMkt Cap
AVNRDown 3.44%N/A
BMYN/A
LLYN/A
GSKN/A

Key Statistics

Forward P/E (1 yr):N/A
P/S (ttm):20.64
Ex-Dividend Date:N/A

Analysts

Annual EPS Est (Sep-14) :-0.29
Quarterly EPS Est (Sep-14) :-0.06
Mean Recommendation*:1.8
PEG Ratio (5 yr expected):-0.42

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

Avanir Pharmaceuticals, Inc., together with its subsidiaries, is engaged in acquiring, developing, and commercializing novel therapeutic products for the treatment of central nervous system disorders primarily in the United States. View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback